IRadimed Corporation
IRMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $760,233 | $667,242 | $697,595 |
| - Cash | $56,526 | $52,996 | $50,331 | $52,234 |
| + Debt | $0 | $0 | $59 | $155 |
| Enterprise Value | – | $707,237 | $616,971 | $645,515 |
| Revenue | $21,202 | $20,409 | $19,511 | $19,389 |
| % Growth | 3.9% | 4.6% | 0.6% | – |
| Gross Profit | $16,494 | $15,955 | $14,843 | $14,761 |
| % Margin | 77.8% | 78.2% | 76.1% | 76.1% |
| EBITDA | $7,681 | $7,920 | $5,626 | $6,539 |
| % Margin | 36.2% | 38.8% | 28.8% | 33.7% |
| Net Income | $5,577 | $5,774 | $4,687 | $5,147 |
| % Margin | 26.3% | 28.3% | 24% | 26.5% |
| EPS Diluted | 0.434 | 0.45 | 0.37 | 0.4 |
| % Growth | -3.6% | 21.6% | -7.5% | – |
| Operating Cash Flow | $6,986 | $7,746 | $4,292 | $5,987 |
| Capital Expenditures | -$1,138 | -$2,824 | -$3,697 | -$3,057 |
| Free Cash Flow | $5,848 | $4,923 | $595 | $2,930 |